ABSTRACT Previous work has shown that two molecules of a soluble form of phosphatidylserine, C6PS, bind to human and bovine factor X a . Activity measurements along with the fluorescence of active-site-labeled human factor X a showed that two linked sites specifically regulate the active site conformation and proteolytic activity of the human enzyme. These results imply, but cannot demonstrate, a C6PS-induced factor X a conformational change. The purpose of this paper is to extend these observations to bovine factor X a and to demonstrate that they do reflect conformational changes. We report that the fluorescence of active-site-labeled bovine factor X a also varied with C6PS concentration in a sigmoidal manner, whereas amidolytic activity of unlabeled enzyme varied in a simple hyperbolic fashion, also as seen for human factor X a . C6PS induced a 70-fold increase in bovine factor X a 's autolytic activity, consistent with the 60-fold increase in proteolytic activity reported for human factor X a . In addition, circular dichroism spectroscopy clearly demonstrated that C6PS binding to bovine factor X a induces secondary structural changes. In addition, C6PS binding to the tighter of the two sites triggered structural changes that lead to Ca 2þ -dependent dimer formation, as demonstrated by changes in intrinsic fluorescence and quantitative native gel electrophoresis. Dimerization produced further change in secondary structure, either inter-or intramolecularly. These results, along with results presented previously, support a model in which C6PS binds in a roughly sequential fashion to two linked sites whose occupancy in both human and bovine factor X a elicits different structural and functional responses.
INTRODUCTION
The activation of prothrombin to thrombin is a crucial step in the blood coagulation process. It is accomplished by the prothrombinase complex, which consists of a serine protease, factor X a , and a protein cofactor, factor V a , interacting on an appropriate acidic membrane surface (Jackson and Nemerson, 1980; Mann et al., 1990) . When compared with factor X a in the presence of factor V a in solution, the activation of prothrombin to thrombin by the prothrombinase complex on an appropriate phospholipid membrane surface is enhanced ;1000-fold (Nesheim et al., 1979; Rosing et al., 1980) . Activated platelets (Kane et al., 1980; Tracy and Mann, 1986) or other cells of the circulatory system (Tracy, 1988; Tracy et al., 1985) can provide the active surface. Several studies (Comfurius et al., 1994; Jones et al., 1985; Rosing et al., 1988) have shown that PS specifically enhances prothrombin activation. We now know that this is due to specific regulatory sites on factors X a and V a (Banerjee et al., 2002a; Koppaka et al., 1996; Srivastava et al., 2002; Zhai et al., 2002) .
Binding of human factor X a to a membrane seems to involve two to four molecules of membrane-associated PS (Cutsforth et al., 1989) . A soluble form of PS, C6PS, binds human factor X a in solution (Koppaka et al., 1996) . Two C6PS molecules bind to either human or bovine factor X a , one to a pair of epidermal-growth-factor-like domains (EGF NC ) when these are linked to an N-terminal g-carboxy-glutamic-acid-rich domain, and one to the catalytic domain . The EGF NC site (site 1), located near the membrane surface, alters the catalytic domain at the other end of human factor X a , including the affinity of the C6PS site in this domain (site 2) (Banerjee et al., 2002a) . Binding of C6PS to the catalytic domain is anomalous and appears to involve part of the substrate recognition site . C6PS binding increases human factor X a 's k cat in prothrombin activation by 60-fold (Koppaka et al., 1996) , with activity seemingly regulated principally by site 1 (Banerjee et al., 2002a) . Site 1 is Ca 2þ -dependent but not Ca 2þ -requiring and minimally binds DAG as a ligand, but requires C6PS to affect activity (Banerjee et al., 2002a) . Site 2 requires Ca 2þ , and its minimal ligand is GPS (Banerjee et al., 2002a) . It can be occupied by acidic lipids other than PS, but not by neutral lipids (Banerjee et al., 2002a; Srivastava et al., 2002) .
PS-containing synthetic membranes have been shown to alter the conformation of prothrombinase complex components. The conformation of prothrombin clearly is altered on binding to a PS-containing membrane (Chen and Lentz, 1997) . Binding of C6PS alters both the structure and cofactor activity of factor V a , such that a fully active prothrombinase is formed in solution when factors V a and X a are incubated in the presence of C6PS . One paper reported a possible effect of PScontaining membranes on factor X a structure by virtue of a change in fluorescence of an active site label, dansyl-GluGly-Arg-chloromethyl ketone (DEGR) (Husten et al., 1987) . We have used the fluorescence of DEGR-X a to follow binding of different soluble phospholipids, with the inference that different changes in fluorescence reflect different structural changes (Banerjee et al., 2002a) . Changes in DEGR-X a fluorescence in response to C6PS have been interpreted in terms of a model that assumes that occupancy of each of the two sites produces different structural changes (Banerjee et al., 2002a) . However, this change in fluorescence of an active-site probe is suggestive of but cannot prove that C6PS induces a conformational change in factor X a , so we report here additional experiments that demonstrate a C6PS-induced conformational change. Specifically, we show: 1), that PS-specific changes in bovine factor X a secondary structure accompany soluble phospholipid binding; 2), that occupancy of the two sites seems to produce different structural responses; 3), that conformational changes associated with occupancy of site 1 lead, in a Ca 2þ -dependent fashion, to factor X a dimerization in solution; and 4), that changes in the autolytic activity of bovine factor X a parallel proteolytic activity changes reported for human factor X a (Banerjee et al., 2002a; Koppaka et al., 1996) .
MATERIALS
DEGR-CK was purchased from Calbiochem (La Jolla, CA). C6PC, C6PG, C6PS, DOPG, POPC, and bovine brain PS were purchased from Avanti Polar Lipids (Alabaster, AL). Factor X a -specific substrate S2765 was purchased from Helena Laboratories (Beaumont, TX). All other chemicals were ACS reagent grade or the best available grade.
METHODS

Short-chain phospholipid preparation
Chloroform was removed from measured amounts of C6PS, C6PG, and C6PC stocks using a stream of nitrogen, and the lipid samples were dissolved in cyclohexane and lyophilized overnight. The lyophilized lipids were then suspended in an appropriate amount of buffer A (50 mM Tris, 0.1 M NaCl, pH 7.5) to reach desired concentrations.
Vesicle preparation
Large unilamellar extrusion vesicles were prepared by the method of Hope et al. (1985) . Dried lipid samples were suspended above their phase transition temperatures in an appropriate amount of buffer A to reach a concentration of roughly 15 mM. The vesicles were then extruded seven times, above their phase transition temperature and under pressure (50-60 psi of Ar), through a 0.1-mm polycarbonate filter (Nucleopore, Pleasanton, CA).
Factor X isolation and activation
Bovine factor X was isolated by barium citrate precipitation from freshly collected bovine plasma (Mann, 1976; Tendian and Lentz, 1990) . Factor X obtained in this manner was analyzed by SDS-PAGE, concentrated (Centricon-10 concentrator, Amicon Division, W.R. Grace, Danvers, MA) and then stored at ÿ708C at a concentration ;1 mg/ml. A final purification step was performed one day before an experiment by dialyzing into low salt buffer, loading onto a Mono Q HR 5/5 ion exchange column (Pharmacia, Norwalk, CT), and eluting by high-performance liquid chromatography on a Perkin-Elmer Isopure LC system using a linear NaCl gradient from 0 to 1M NaCl. The purified factor X was dialyzed into buffer A for activation.
Factor X was activated with a purified fraction of Russel's viper venom factor X activating protein (RVV-X; Hematological Technologies, Essex Junction, VT) that had been covalently linked to Affigel-15 (Bio-Rad, Hercules, CA) agarose beads (Jesty and Nemerson, 1976) . The cleavage of a single arginyl-isoleucine peptide bond in the heavy chain of factor X results in the formation of factor X aa . Factor X aa is slowly degraded to give rise to factor X ab (Fujikawa et al., 1974) . The two forms of factor X a obtained were analyzed by SDS-PAGE on a 10% gel. A high concentration of factor X aa relative to factor X ab was obtained for autolysis experiments by controlling the time of factor X incubation with RVV beads. Sodium citrate was then added to stop the reaction and the RVV beads were removed by centrifugation. We performed a series of experiments to define the optimal reaction time (25 min) to minimize the amounts of factor X and factor X ab under our experimental conditions. Under these conditions, the final reaction mixtures contained ;85-90% factor X aa , 5-10% factor X, and 2-5% factor X ab as averaged from several preparations. The supernatant, containing mainly factor X aa , was used immediately for autolysis measurements. Factor X a , which, under normal conditions consists mainly of factor X ab , was prepared for structural studies (CD or fluorescence) by incubating RVV beads with factor X in buffer A with 5 mM Ca 2þ for at least 90 min at room temperature. Purified factor X a was obtained by high-performance liquid chromatography using a Mono Q column, as described for factor X. Factor X a concentration was determined from the rate of S2765 hydrolysis in a plate-reader-based assay (Koppaka et al., 1996) , using active-site-titrated factor X a (Jameson et al., 1973) to construct the standard curve.
DEGR-X a preparation
DEGR-X ab and DEGR-X aa were prepared by sequential addition of 5 mL aliquots of DEGR-CK (;1 mg/ml in 0.02 M Tris-HCl, 0.1 M NaCl, pH 7.5 buffer) to 1.0 mL of factor X ab or factor X aa at ;17 mM. The extent of labeling at the active site was followed by the loss in enzymatic activity, as monitored by the rate of S2765 hydrolysis. DEGR-CK addition continued until no activity remained. DEGR-X a was then dialyzed in buffer A to remove free reagent (Husten et al., 1987) and analyzed by SDS-PAGE and detected with a Foto/Prep II transilluminator (VWR Scientific, Norwalk, CT) and with Coomassie blue to confirm that the probe was associated with factor X a .
Kinetic measurements of factor X a autolysis
Several samples containing 6.5 mM factor X aa but different concentrations of lipid were followed simultaneously. Each sample was brought to 5 mM in CaCl 2 to start the reaction. Aliquots (15 mL) were removed from each sample at different times into preprepared SDS-sample buffer and then immediately heated for ;2 min at 1008C. A Multichannel Digital Finnpipette (Labsystems, Finland) was used to add calcium to or remove samples from the reaction mixtures to assure that reaction times were carefully coordinated. The relative amounts of factors X aa and X ab were obtained from the relative intensity of the corresponding SDS-PAGE gel bands measured on a scanning densitometer (Mitsubishi Model SLR-2D/1D, Fotodyne, Cyprus, CA).
Fluorescence measurements
The fluorescence intensity of DEGR-X a was recorded at 228C with an SLM 48000 fluorescence spectrophotometer (SLM Aminco, Rochester, NY), using an excitation wavelength of 340 nm (band pass 8 nm) and emission wavelength of 550 nm (4-nm band pass). Slits were kept closed except during measurements to avoid photodegradation of the sample. Before each titration, DEGR-X a was incubated in buffer A with Ca 2þ for ;20 min. Short-chain phospholipids were added in 2 or 3 mL aliquots, with a maximum dilution of 4%. To correct for dilution, we measured the emission intensity of DEGR-X a in response to titration by buffer A. Fluorescence intensity was recorded ;2 min after each addition. For each lipid, several parallel measurements were performed and results were averaged.
Data were analyzed according to the binding models described in the Appendix. Nonlinear least squares fitting was accomplished using SigmaPlot (version 4.0 for Windows; Jandel Scientific). We judged the relative appropriateness of different models for describing each data set by comparing the correlation coefficients of the fit (R 2 ) and the sample variances (s) using an F-test (Bevington, 1969) . R 2 is the adjusted square of the correlation coefficient; values close to 1 indicate that the model provides a good description of the variation of the dependent variable with the independent variable. s is the ''standard error of the estimate'' or ''sample variance'' (the square root of the quantity, sum of squared residuals divided by the number of degrees of freedom). It gives a measure of the variability of the data about the regression plane. A smaller value means a better fit of the regression equation to the parent data set (Bevington, 1969) .
Intrinsic fluorescence of factor X a was recorded at 228C while exciting at 285 nm with an 8-nm excitation band pass on the SLM 48000 fluorescence spectrophotometer. Scans were collected from 310 to 390 nm in ratio mode and corrected for instrumental response. Scans of buffer or buffer plus C6PS were recorded and subtracted from scans obtained with factor X a to correct for background scatter.
Effect of phospholipids on factor X a activity
The amidolytic activity of factor X a in the presence of soluble phospholipids and Ca 2þ was determined using the synthetic substrate S2765 (0.49 mM) and a microplate reader (SLT 340 ATTC; SLT Instruments, Hillsborough, NC), as described previously (Koppaka et al., 1996) . The buffer was a modified form of buffer A containing 0.6 wt % poly(ethylene glycol) to prevent factor X a from adsorbing to the plate. The effect of C6PS on factor X a amidolytic activity has been shown previously to be independent of substrate concentration up to 1 mM, allowing us to conclude that the effect of C6PS was not due to C6PS binding to substrate (Koppaka et al., 1996) .
Circular dichroism measurements
CD spectra were recorded from 250 to 200 nm on an Aviv Model 620S spectrometer (Aviv Associates, Lake Wood, NJ) in a 1-cm pathlength cell at 258C with a bandwidth of 1 nm. Samples were prepared in buffer B (1.2 mM Tris, 150 mM NaCl, pH 7.4). Because correlating structural and functional changes was our goal, we adopted this buffer to maintain a similarity to buffer A used in activity and fluorescence measurements. When we collected spectra in a very low-salt, Na þ -free buffer down to 185 nm, the effects of Ca 2þ and C6PS seen in physiological buffer could not be reproduced (Srivastava and Lentz, unpublished observations) . This probably reflects the documented linkage between Na þ and Ca 2þ binding to factor X a (Rezaie and He, 2000; Underwood et al., 2000) and the influence of Ca 2þ on C6PS binding (Koppaka et al., 1996) . Because a buffer with physiological ionic strength is not very transparent in the deep UV, this precluded complete secondary structure analysis that requires data down to 185 nm, although estimates of a-helix content could be made based on spectra collected to 200 nm (Johnson, 1990) . Data points were collected every 0.5 nm with a 5-s average time for each point. The digital data were processed, smoothed, baseline-corrected, and converted to molar ellipticity, [Q] . For baseline corrections, CD spectra were collected for C6PS, C6PG, and C6PC in buffer with the same concentrations as for sample titration in the presence or absence of Ca 2þ . All buffer-corrected spectra were flat with roughly zero molar ellipticity from 245 to 250 nm except at high short-chain lipid concentration when this portion of the spectrum dipped dramatically. The lipid concentration range in which this happened for C6PS was shown by quasi-elastic light scattering (QELS) to correspond to the C6PS critical micelle concentration (CMC) (Koppaka et al., 1996) . Because the proteolytic activity of factor X a abruptly increased by 1.7-fold at the C6PS CMC (Koppaka et al., 1996) , it is clear that factor X a binds to C6PS micelles, and we did not attempt to analyze data at or above the CMC of any of the lipids examined.
Native gel electrophoresis to estimate the molecular weight of factor X a Polyacrylamide gels were prepared at four different percentages of crosslinking (5%, 6%, 8%, and 10%). Factor X a and known marker proteins (270 kDa-14.2 kDa; Sigma, St. Louis, MO) were run on these gels in a BioRad Mini-Protean II minigel apparatus (Biorad Corp., Hercules, CA) and stained with colloidal Coomassie blue (Mitra et al., 1994) . The R f of each protein in each gel was measured relative to the tracking dye. For each protein, a plot of log (R f 3 100) against the percent gel concentration gave a straight line, the negative slope of which is the retardation coefficient (Ferguson, 1964) . A log-log plot of the retardation coefficient against the molecular weights of the marker proteins produces a linear curve from which the molecular weight of any unknown protein may be determined (Bryan, 1977) .
RESULTS
Response of bovine DEGR-X a to C6PS, C6PG, and C6PC parallels response of human DEGR-X a One purpose of this paper was to confirm that responses of bovine factor X a to C6PS are due to structural changes. Because many of our previous studies were performed with human factor X a , we focus first on demonstrating the essential equivalency of the bovine and human forms of factor X a in their reactions to short-chain lipid binding. Addition of C6PS to bovine DEGR-X a , preincubated with 5 mM Ca 2þ , led to a saturable decrease in emission intensity that paralleled changes observed with human factor X a (Banerjee et al., 2002a) and indicated a change in the environment of the dansyl moiety at the active site ( Fig. 1 A, filled circles). Titration of bovine DEGR-X a with PS/POPC (1/3) membranes produced a 55% drop in DEGR-X a fluorescence (data not shown), consistent with but roughly twice that seen with C6PS and consistent with a literature report (Husten et al., 1987) .
The discontinuity that occurs in the intensity of bovine DEGR-X a between 700 and 800 mM C6PS corresponds to the CMC (800 mM) observed for C6PS at 5 mM CaCl 2 in the presence of 5 nM human factor X a (Koppaka et al., 1996) . The discontinuity observed at 5 mM Ca 2þ was not observed at lower Ca 2þ concentrations ( Fig. 1 B) , because the C6PS CMC increases dramatically with increasing Ca 2þ concentrations (Koppaka et al., 1996) . Because factor X a binds to C6PS micelles above the CMC (Koppaka et al., 1996) , titration curves were fit to binding models only for lipid concentrations below the CMC.
Because of its S-shape, the C6PS binding isotherm was not well described by a single-site-binding model (R 2 /s ¼ 0.98/0.0086; Fig. 1 , dotted curve). However, a cooperative model that assumes two linked sites having equivalent structural responses (Klotz and Hunston, 1975 ) was, as expected, able to reproduce the S-shape of the binding isotherm (fit not shown; stoichiometric dissociation constants K d1 ; 10.7 mM, K d2 ; 14 mM; R 2 /s ¼ 0.998/0.0034). Because the C6PS CMC is 1.5 mM in the presence of factor X a and 3 mM Ca 2þ (Koppaka et al., 1996) , we were able to obtain data up to higher concentrations of C6PS at 3 mM Ca 2þ ( Fig. 1 B, squares) , making the failure of the singlesite-binding model especially clear (dotted curve; R 2 /s ¼ 0.97/0.0097). Just as for human factor X a (Koppaka et al., 1996) , C6PS binding was much less tight at Ca 2þ concentrations below 3 mM (Fig. 1 B) . In the absence of Ca 2þ , the fluorescence of DEGR-X a ( Fig. 1 B, filled diamonds) increased in response to C6PS, as we have observed for human DEGR-X a (Banerjee et al., 2002a) . This increase was well described by a single site model ( Fig. 1 B, dotted curve through filled diamonds ) with a k d of 200 6 17 mM and a DR sat of 0.047 6 0.001.
Although we did not examine all the short-chain lipid analogs that we did for human factor X a , we did consider responses to C6PG and C6PC. The response of DEGR-X a fluorescence to titration with C6PG at 5 mM Ca 2þ ( Fig. 1 C, filled circles) shows that this lipid binds to bovine factor X a and elicits a sigmoidal response, as it does with human DEGR-X a (Banerjee et al., 2002a) . No discontinuity was detected in the titration of DEGR-X a with C6PG, inasmuch as the C6PG CMC at 5 mM Ca 2þ in the absence of protein is much larger (;14 mM) than that of C6PS (0.95 mM) (Koppaka et al., 1996) . In the absence of Ca 2þ , C6PG produced a positive change in DEGR-X a fluorescence ( Fig. 1 C, diamonds), although this change was so small (DR sat ¼ 0.010 6 0.001) that the apparent k d for this interaction could not be determined with certainty.
The response of DEGR-X a to C6PC at 5 mM Ca 2þ (Fig. 1 C, closed triangles) was qualitatively different from the response to either C6PS or C6PG in that there was no sigmoidal shape to the titration curve, and C6PC caused a slight increase rather than a decrease in emission intensity. The C6PC CMC under these conditions is ;9 mM (Koppaka et al., 1996) . The dotted curve drawn through these data represents the best fit of the data to a single-site-binding model, which yielded a k d of 436 6 160 mM and a DR sat of 0.025 6 0.003. The response to C6PC in the absence of Ca Effect of short-chain phospholipid on bovine factor X a amidolytic activity
We reported previously that both soluble C6PS and membrane-associated PS inhibited amidolytic activity of human factor X a to a comparable extent (Fig. 6 of Koppaka et al., 1996) . To assure that the bovine protein had a functional response to C6PS similar to that of the human protein, we report in Fig. 2 the amidolytic activity of bovine factor X a (relative to the activity in the absence of C6PS) as a function of C6PS concentration in the presence (triangles: FIGURE 1 (A) DEGR-X a (filled circles) at 100 nM in buffer A (50 mM Tris, 0.1 M NaCl, pH 7.5) was titrated at 228C with C6PS in the presence of 5 mM Ca 2þ . Fluorescence intensities were measured 2 min after addition of lipid. Fit to the single-site model (Eq. 1) (dotted lines) and the sequentiallinked-site model (Eq. 1) (solid line) are shown. Parameters resulting in these fits are given either in the text or in Table 1 . (B) DEGR-X a (100 nM) in buffer A was titrated with C6PS in the presence of 3 mM (squares) and 1 mM (inverted triangles) CaCl 2 and in the absence of CaCl 2 (diamonds). Fits to the data are as described in A. (C) DEGR-X a (100 nM) in buffer A was titrated with C6PG (filled circles) and C6PC (filled triangles) in the presence of 5 mM Ca 2þ ; with C6PG in the presence of 1 mM (filled inverted triangles) Ca 2þ or no Ca 2þ (filled diamonds); with C6PC in the absence of Ca 2þ (open triangles). Fits to the data are as described for A.
2 mM; circles: 5 mM) and in the absence (squares) of Ca 2þ . As for human factor X a (Koppaka et al., 1996) , the amidolytic activity of bovine factor X a was inhibited by C6PS. The site dissociation constant (98 mM) obtained from a least-squares fit of the 5 mM Ca 2þ data to a single-site model is somewhat higher than we have reported for C6PS effect on human factor X a (67 mM) (Koppaka et al., 1996) .
Binding was weaker at lower Ca 2þ concentrations (k d 190 mM at 2 mM Ca 2þ ), as also seen for the human protein (Koppaka et al., 1996) . In the absence of Ca 2þ , C6PS had no effect on activity of either the bovine or human protein.
Effect of soluble phospholipids on the rate of factor X aa autolytic activity Bovine factor X can be activated by two alternative pathways (Fujikawa et al., 1974; Jesty et al., 1974 Jesty et al., , 1975 . The first is initiated by the action of factor VII a or RVV on factor X to cleave an activation peptide from the amino terminus of the heavy chain to produce factor X aa . Factor X aa is then converted autocatalytically to factor X ab with the loss of a 17-residue glycopeptide from the carboxy terminus of the heavy chain. The conversion of factor X aa to factor X ab is lipid dependent. The alternative pathway is initiated by the action of factor X a on factor X in the presence of lipid to produce factor X ab . Fig. 3 shows the time course of the appearance of factor X ab due to autolysis of factor X aa , as monitored by SDS-PAGE in the presence of 5 mM CaCl 2 and various concentrations of soluble phospholipids or membranes. The fraction of factor X a in the b (autolyzed) form was estimated from intensities of SDS-PAGE gel bands (gels not shown). Of the three short-chain lipids examined (C6PC, closed circles; C6PG, filled inverted triangles; C6PS, filled triangles), only C6PS produced a significant enhancement ($70-fold) in the rate of factor X aa autolysis relative to the This value fixed based on titration of activity for C6PS or results 6Ca 2þ for C6PG. z A t-test on this parameter produced a P . 0.05%, where P is the probability of being wrong in concluding that the parameter is zero. This indicates that this parameter value is ill determined. § These parameter values were constrained such that DR sat,1 . 0, DR sat,12 , 0. ND (not determined). NA (not applicable) means that these data did not support this analysis. FIGURE 2 Relative rates of S-2765 hydrolysis by bovine factor X a (5 nM) as a function of C6PS in the presence of 5 mM Ca 2þ ( filled circles), 2 mM Ca 2þ ( filled triangles), and in the absence of Ca 2þ ( filled squares) were determined at 378C in a buffer containing 50mM Tris, 175 mM NaCl, 0.6% PEG, at pH 7.6. The data are expressed as a fraction of the rate of S2765 hydrolysis by factor X a in the absence of C6PS. The lines indicate the fits of the data to a model assuming a single C6PS site on factor X a , yielding dissociation constants of 190 and 98 mM in the presence of 2 and 5 mM Ca 2þ , respectively. rate in the absence of lipid (open diamonds). This rate enhancement occurred below the CMC for C6PS observed in the presence of factor X a (0.8 mM (Koppaka et al., 1996) ). At or above the CMC, C6PS micelles induced an even greater increase (from $170-to 230-fold) in the rate of X aa autolysis (0.8 mM C6PS, filled squares; 1.36 mM, filled diamonds). The rate enhancement of factor X aa autolysis by C6PS is contrasted in Fig. 3 to the rate enhancement induced by PS/POPC (1/3) membranes (220-fold; open circles). Clearly, the largest part of the autolysis rate enhancement in the presence of a PS-containing membrane is due to the PS molecule, but there is roughly a two-to threefold increased rate due to the presence of an interface, be it a membrane or micelle interface. These data agree with the 60-fold increase in proteolytic activity that we have reported (Koppaka et al., 1996) for the effect of C6PS on the proteolytic activity of human factor X a against prothrombin and show conclusively that the effect of C6PS is on factor X a and not on its substrate prothrombin. They also agree with our finding for human factor X a that the effect of a PS membrane or micelle surface is only two-to threefold greater than the effect of C6PS in solution (Banerjee et al., 2002b) . DOPG/POPC membranes (open squares) did enhance the reaction rate by 18-fold, but the rate was much lower than that observed in the presence of soluble or membrane-associated PS. POPC membranes produced only a fivefold increase in the rate of factor X a autolysis (open triangles).
In summary, both active-site-labeled bovine DEGR-X a and unlabeled bovine X a respond to different soluble lipids in a fashion analogous to the response of the human protein, except that lipid binding to the human protein was in general a bit tighter than was binding to the bovine protein. The response of factor X a activity to C6PS was hyperbolic whereas that of DEGR-X a fluorescence was sigmoidal in shape.
C6PS triggers factor X a dimerization
To test the possibility that the difference in structural and functional responses might be that these experiments were performed at very different factor X a concentrations (100 nM for fluorescence and 5 nM for activity measurements), we titrated 1 nM DEGR-X a in the presence of 5 mM Ca 2þ with C6PS. The response was no longer sigmoidal (Fig. 4, open  triangles) . Nor was it simply hyperbolic, inasmuch as a single-site model could not describe the data either, as seen from the dotted curve drawn through the triangles in Fig. 4 . The difference in response of DEGR-X a to C6PS at 1 and 100 nM DEGR-X a might be an artifact associated with pressing the limits of sensitivity of our fluorometer at 1 nM DEGR-X a . To test for this possibility, we performed a titration at yet a third DEGR-X a concentration (150 nM). The resulting response curve (Fig. 4, open circles) showed a clear sigmoid shape but differed in the magnitude of the response from data obtained at 100 nM factor X a (compare to Fig. 1 A) . Clearly, the response to C6PS varied with protein concentration, suggesting that factor X a might self-associate, at least under the influence of C6PS, and that self-association might influence the observed response to C6PS.
To test for possible C6PS-induced factor X a selfassociation, we recorded factor X a intrinsic fluorescence spectra as a function of protein concentration, in the presence and absence of 600 mM C6PS and/or 5 mM Ca 2þ (data not shown) and found complex changes in intrinsic fluorescence with increasing factor X a concentration. In Fig. 5 , we present the intensity of the Trp peak of factor X a intrinsic fluorescence as a function of factor X a concentration. Not surprisingly, the intensity of factor X a alone increased linearly with factor X a concentration in the presence (frame A, closed circles) and absence (frame C, closed squares) of Ca 2þ . Even in the presence of C6PS, the intrinsic fluorescence increased in a linear fashion in the absence of Ca 2þ (Fig. 5 C, closed inverted triangle). However, the fluorescence intensity in the presence of both Ca 2þ and C6PS increased in a saturable fashion and then increased linearly with factor X a concentration (Fig. 5 B, filled triangle) . The linear increase of fluorescence represented by the straight line in Fig. 5 B was subtracted from the whole curve in this frame, and the saturable residual curve is shown in the inset to Fig. 5 B. These data were fit to a dimerization model (Eq. 2 in Appendix) to yield a dimer dissociation constant of 20 nM. Similar experiments were performed at several Ca 2þ concentrations with the resulting dimer dissociation constants shown as a function Ca 2þ concentration in Fig. 6 A. The response of human factor X a activity to C6PS, which is dominated by binding to site 1 (Banerjee et al., 2002a) , shows a very similar Ca 2þ dependence (Koppaka et al., 1996) . Fig. 6 B shows the variation of dimer association constants with C6PS concentration. A hyperbolic fit to this curve gave an apparent K d of 96 mM, the same K d obtained for site 1 (K d 98 mM, Fig. 2 ). Thus, both the Ca 2þ -and C6PS-dependences of dimerization indicate that occupancy of site 1 site triggers dimerization.
To obtain a direct measure of factor X a self-association under a variety of conditions, native polyacrylamide gel electrophoresis was performed. A sample 7% gel is shown as an inset to Fig. 7 and demonstrates that both monomer and dimer were easily resolved. No higher order aggregates were observed at the stacking/running gel interface of any experiment (Fig. 7, top of gel ) . From these gels, the retardation coefficient of each protein was obtained as FIGURE 5 The intrinsic tryptophan fluorescence intensity of factor X a recorded at 344 nm is plotted as a function of factor X a concentration in the presence of Ca 2þ (A, closed circle) and in the absence of 5 mM Ca 2þ in the presence (closed inverted triangle) and absence (closed square) of 600 mM C6PS (C). (B) Factor X a intrinsic fluorescence intensity is plotted as a function of factor X a concentration in the presence of 650 mM soluble C6PS (closed triangle). The lower inset to B shows the data in this frame with the limiting linear increase of fluorescence intensity (line through the data at higher X a concentrations) subtracted. When these data were fit to a simple dimerization model (see text), a dimerization k d of ;20 nM was obtained. described in Methods. Fig. 7 shows a plot of log (retardation coefficient) versus log (molecular weight) (Ferguson, 1964) for four marker proteins ( filled circles) and 100 nM factor X a in the absence of Ca 2þ ( filled triangle; 47 6 1.5 kDa). The molecular mass of bovine factor X a is reported by amino acid and carbohydrate analysis to be 45 kDa (Jesty and Nemerson, 1976 ). In the presence of 400 mM C6PS, the molecular mass of factor X a was 114 6 1.7 kDa at 5 mM Ca 2þ (Fig. 7,  star) . From the ratio of these molecular masses (2.4), it seems most likely that factor X a forms a dimer in the presence of soluble C6PS, with the shape of the dimer causing it to run at slightly greater than twice the molecular mass of the monomer. The fraction of factor X a involved in dimer under these conditions was 85% (calculated from the dimerization constant recorded in Fig. 6 and obtained as in Fig. 5 ), whereas the fractions of material in the dimer and monomer bands of lane 4 of Fig. 7 were found from densitometry to be 83 and 17%, respectively. The fact that the distribution of material in the gel reflects the equilibrium distribution in solution suggests that dissociation is slow. It also provides direct validation of our use of intrinsic fluorescence to obtain dimerization constants. A gel run in the presence of 400 mM C6PS but at 1 nM FX a showed that only monomer with a molecular mass of 46 6 1.6 kDa (data not shown) existed under the conditions of the open triangles in Fig. 4 . A control experiment with 100 nM X a , 2 mM Ca 2þ , and 100 nM X a showed a monomer (Fig. 7, diamond) of 47 6 0.8 kDa, verifying the Ca 2þ -dependence of factor X a dimerization shown in Fig. 6 A. Finally, an experiment performed at 5 mM Ca 2þ with 400 mM C6PC and 100 nM X a also showed only monomer X a (data not shown), demonstrating the specificity of C6PS-induced dimerization. Sedimentation velocity experiments have shown bovine factor X a to be a 45 kDa monomer in solution in the presence of Ca 2þ (Pryzdial and Mann, 1991) . Our results agree with this, but clearly show that factor X a dimerizes in the presence of C6PS.
We conclude that bovine factor X a forms a dimer under the influence of C6PS binding to site 1 and that the different responses seen for titration of DEGR-X a fluorescence at 100 and 1 nM factor X a probably reflect different structural responses elicited by C6PS from the two aggregation states of factor X a . Thus, binding of C6PS to bovine factor X a alters its activity, active site environment, and aggregation state in solution. This strongly implies a structural change, the possibility of which we address next with a direct structural measurement.
Effects of short-chain phospholipids on factor X a secondary structure CD specta of factor X a at various concentrations of soluble lipids (Fig. 8) are notable for their lack of a pair of negative peaks at 208 and 222 nm that characterize a-helical secondary structure (Johnson, 1990) . Instead, the spectrum is dominated by a single negative band whose peak varies from 203 to 206 nm, depending on the presence of Ca 2þ and/ or C6PS. This implies that factor X a in solution consists mainly of b-structures and little a-helix, as confirmed by spectral analysis (Sreerama and Woody, 2000) (11% a-helix, with and without Ca 2þ ). Of course, analysis of these spectra taken only to 200 nm could yield no useful information about b-or disordered structures (Johnson, 1990) . However, analysis of spectra carefully collected to 185 nm in saltfree buffer confirmed the presence of only 11% a-helix, with b-structures (sheets and turns) accounting for 60% of the FIGURE 7 Factor X a was analyzed by native polyacrylamide gel electrophoresis in buffer A plus 5 mM CaCl 2 as described in Methods. Retardation coefficient for different reference proteins were obtained from plots of log R f versus percent cross-linking (5%, 6%, 8%, and 10%). A log-log plot of retardation coefficient is shown for these reference proteins (closed circles). Points have been added to this plot for retardation coefficients obtained for 100 nM factor X a with 5 mM Ca 2þ in the absence (closed triangle) or presence (closed star) of 400 mM C6PS and also with 2 mM Ca 2þ and 400 mM C6PS (closed diamond). The inset shows lanes from the 7% gel (lane 1-markers, lane 2-100 nM X a with 2 mM calcium and 400 mM C6PS, lane 3-100 nM X a with 5 mM Ca 2þ without C6PS, lane 4-100 nM X a with 5 mM Ca 2þ and 400 mM C6PS) with bands noted by arrows from the points on the Ferguson plot (Ferguson, 1964) . spectral shape. Although the crystal structure of whole bovine factor X a has not been determined, the crystal structure of the highly homologous human factor IX a has 13% a-helix and 23% b-sheet, with b-turns not tabulated (from the Protein Data Bank based on Brandstetter et al. (1995) .
Because the major features of the spectra in Fig. 8 are consistent with what information we have about the secondary structure of factor X a , we may use this approach to monitor changes in factor X a secondary structure associated with binding of soluble lipids. Because we could not obtain the deep UV spectra needed for a detailed secondary structure analysis (Johnson, 1990) , we used the ratio of ellipticity at 222 nm to that at 208 nm (Q 222 /Q 208 ) (Greenfield and Fasman, 1969) as well as estimates of the fraction of a-helix (Sreerama and Woody, 2000) to monitor changes in secondary structure induced by binding of soluble lipids.
Although the CD spectrum of factor X a was slightly redshifted on addition of Ca 2þ (compare solid lines in Fig. 8 B to Fig. 8 A) , there was no significant change in the Q 222 /Q 208 ratio (0.52 in both cases) or in our estimate of helical content (11% in both cases). Fig. 8 A also shows that addition of 600 mM C6PC (dot-dot-dashed line), C6PG (dotted line), or C6PS (dot-dashed line) to factor X a in the presence of 3 mM Ca 2þ caused shifts in bovine factor X a secondary structure. All three lipids changed the shape of the CD spectrum. These changes were clearly detectable both as reproducible changes in the Q 222 /Q 208 ratio at increasing concentrations of C6PC (triangles), C6PG (squares), or C6PS (circles) (Fig. 8 A, inset) , and as changes in a-helical content (ÿ1, þ2.8, and þ6%, respectively). These results are consistent with the different changes in DEGR-X a fluorescence seen for the three different lipid species, in that C6PC-and C6PG-induced different conformational changes in factor X a , with both of these different from the large changes induced by C6PS. Because the Q 222 /Q 208 ratio increased for all three lipids, but the a-helical content decreased for C6PC, it is clear that changes in the Q 222 /Q 208 ratio reflected more than just changes in helix content. Fig. 8 B shows that the CD spectrum of factor X a also changed upon addition of C6PS, C6PG, and C6PC in the absence of Ca 2þ , but these soluble lipids induced different conformational changes (inset) than seen in the presence of Ca 2þ , consistent with our DEGR-X a titration results (Fig. 1) . As for the DEGR-X a results, the response of factor X a secondary structure to C6PC was the same in the presence (Fig. 8 A, inset) or absence (Fig. 8 B, inset) of Ca 2þ . Inasmuch as C6PS induces dimerization in the presence of Ca 2þ , the changes observed in the presence of Ca 2þ could represent changes in secondary structure associated with intermolecular structures formed upon dimer formation. Even minimal conditions for CD experiments (2mM Ca 2þ and 200 nM X a ) will produce a small amount of dimer (;5-7% of X a from Fig. 6 B) when C6PS occupies site 1. It was thus impossible to measure directly the effect of C6PS on the CD spectrum of monomeric factor X a without inducing some dimer formation. Thus, we resorted to taking a series of spectra under conditions that should result in decreasing dimer formation. Spectra taken in the presence of 3 mM Ca 2þ and 600 mM C6PS, but at 300 and 200 nM factor X a , showed decreasing negative peaks at 208 nm (data not shown). A spectrum taken at 5 mM Ca 2þ , 600 mM C6PS, and 600 nM factor X a , for which even more X a should be dimer, had an even larger negative ellipticity minimum (data not shown). From the factor X a dimerization constant observed at 3 and 5 mM Ca 2þ and 600 mM C6PS (Fig. 6  A) , we calculated the fraction of X a involved in dimer formation under these varying conditions and plot the Q 222 / Q 208 ratio as a function of this in the upper inset to Fig. 8 A. The intercept of a straight line through these data predicts FIGURE 8 (A) Factor X a (0.6 mM) in buffer B (1.2 mM Tris, 150 mM NaCl, pH 7.4) was examined at 248C in the presence of 3 mM CaCl 2 (solid line); and in the presence of 0.6 mM C6PS (dot-dash-dot line), C6PG (dotted line), and C6PC (dot-dot-dashed line) with 3 mM CaCl 2 . (B) Factor X a (0.6mM) in buffer (1.2 mM Tris, 150 mM NaCl, pH 7.4) was examined at 248C (solid line); and in the presence of 0.6 mM C6PS (dot-dash-dot line), C6PG (dotted line), and C6PC (dot-dot-dashed line) in the absence of CaCl 2 . In the lower insets to A and B, the effects of C6PS (circles), C6PG (squares), and C6PC (triangles) concentrations on Q 222 /Q 208 ratios measured from CD spectra of factor X a in the presence of 3 mM Ca 2þ (A) or in the absence of Ca 2þ (B). The upper inset to A shows the variation of Q 222 /Q 208 ratio with fraction of X a present as dimer (obtained using k dimer from the upper inset to Fig. 6 B) for factor X a concentrations of 200, 300, and 600 nM.
that factor X a monomer bound to C6PS in the presence of Ca 2þ would give a Q 222 /Q 208 ratio of 0.44, nearly the same value seen for monomer factor X a at saturating C6PS concentration in the absence of Ca 2þ (0.45; Fig. 8 B, inset) . This implies that the secondary structural change seen in response to C6PS in the presence of Ca 2þ results in part from dimer formation and in part from a change in secondary structure associated with C6PS binding to monomer factor X a .
DISCUSSION
Both human and bovine factor X a have two soluble-lipidbinding sites, site 1 in the EGF NC domain pair that is Ca 2þ -dependent and site 2 in the catalytic domain that is Ca 2þ requiring and probably corresponds to part of a protein recognition site rather than being a lipid regulatory site . In addition, other studies of DEGR-X a fluorescence and factor X a activity have shown that these two sites in human factor X a are linked, that they have different minimal lipid specificities, and that site 1 is principally involved in regulating factor X a activity (Banerjee et al., 2002a) . While these studies suggest that factor X a activity is regulated via structural changes induced by C6PS binding, they provided no direct proof of C6PS-induced protein structural changes. To demonstrate C6PS-induced structural changes, we focused in the current paper on bovine factor X a , which is available more inexpensively in the large quantities needed for structural work. The first part of the results in this paper establish that bovine factor X a behaves analogously to human factor X a with respect to C6PS binding, making it reasonable to assign responses observed for one of these very similar forms of factor X a to the other. The second part of this work leads to three significant conclusions about the effect of PS molecules on bovine factor X a :
1. The two sites on bovine factor X a differ in their response to Ca 2þ and to different lipid species. Site 1 is occupied by C6PG and C6PC with similar affinity (k d ; 200 mM) in the presence or absence of Ca 2þ but with higher affinity by C6PS in the presence (k d ; 90-100 mM) than in the absence (k d ; 200 mM) of Ca 2þ . This is the EGF NC site that recognizes DAG as a minimal ligand in human factor X a (Banerjee et al., 2002a) . Site 2 does not bind C6PC and requires Ca 2þ to bind C6PS (k d ; 160-250 mM) or C6PG (k d ; 700-1100 mM). This site is in the catalytic-domain site and in human factor X a recognizes GPS as a minimal ligand (Banerjee et al., 2002a) . 2. Description of C6PS or C6PG binding to these sites minimally requires the sequential-linked-site model. The requirement for something like this model derives from the different response of DEGR-X fluorescence (sigmoidal; Fig. 1 ) and factor X a activity titration (hyperbolic; Fig. 2 ) to C6PS, a situation that also exists for human factor X a (Banerjee et al., 2002a; Koppaka et al., 1996) . There is no way to justify these observations within the context of the traditional linked-site model (Klotz and Hunston, 1975) in which both sites respond with the same structural or functional change. This is because assigning a site dissociation constant (k d ) of 90-100 mM (the binding constant obtained from titration of factor X a activity, Fig. 2 ), and using published procedures for calculating site constants from stoichiometric constants with one site constant known (Klotz and Hunston, 1975) led to physically unreasonable estimates of the other two independent site dissociation constants for the interaction of C6PS with factor X a . The basic problem is that the fit provided by the linked-site model requires that tight binding should occur only once a weak site is occupied, and this was not the behavior seen for the response of activity to C6PS (Fig. 2) . Because competitive and cooperative binding experiments with different lipid species demonstrate that the two lipid binding sites on human factor X a are linked (Banerjee et al., 2002a) , we have concluded that a more complex linked-site model is needed to describe our data for C6PS binding to factor X a . The sequential-linked-site model described in the Appendix is the simplest model that we have found accounts for our observations. In fitting our data to this model, we fixed the dissociation constant assigned to site 1 (90 mM), leaving three adjustable parameters, which, for the most part, were well defined by the regression process. This model provided an adequate description of data at both low (1nM) and high (100 or 150 nM) DEGR-X a concentrations, as documented in Figs. 1 and 4 (solid lines) and Table 1 . A likely explanation for the simple hyperbolic response of factor X a activity (Fig. 2) is that occupancy of only one of the sites on factor X a (the first or EGF NC site) dominates the activity response but that occupancy of both sites produces an increase in activity, as demonstrated quantitatively for human factor X a (Banerjee et al., 2002a) . Despite the empirical success of this model, the behavior of factor X a is clearly more complex than it suggests. Thus, the model assumes that the two sites are occupied sequentially to produce different structural responses in the singly bound and doubly bound species. However, we know that GPS can weakly (k d 0.8 mM) occupy site 2, but that occupancy is much tighter (k d 0.09 mM) if DAG occupies site 1 (Banerjee et al., 2002a) . This means that the ''sequential'' aspect of our model is an approximation, but a reasonable approximation that reduces the number of unknown parameters from six to four (see Appendix). The sequential-linked-site model is also an approximation in that we show here that C6PS triggers X a dimer formation (Figs. 6 and 7 ), but the model does not take into account dimerization. Thus, any response that we see to C6PS includes structural responses of binding to monomer as well as the consequences of dimer formation. Indeed, a possible interpretation of our DEGR-X a fluorescence data is that C6PS binding to site 1 in monomer X a might trigger conformational changes that expose the DEGR probe to water (negative DEGR fluorescence change at low DEGR-X a concentration, Fig. 4 and Table 1 ), while these same conformational changes might induce dimer formation that then buries the DEGR probe at a dimer interface (positive DEGR fluorescence change, Fig. 1 and Table 1 ). At higher C6PS concentration, a negative fluorescence change would dominate. To test this interpretation, we formulated the dimer-sequential model (Appendix) that allows for factor X a bound to a single molecule of C6PS to exist as either a monomer or a dimer. This introduced another unknown parameter (the fluorescence change associated with the C6PS-bound monomer, DR 1 in Eq. A3). The extra free parameter naturally improved somewhat the fit to our data, but also led to poorly determined saturating fluorescence changes for each presumed species (see Table 1 ). Nonetheless, the binding parameters that could be determined from regression of this model to the data (k d1 , k d12 , and DR sat,12 ) were consistent with the corresponding parameter values obtained using the linked-site, sequential model (Table 1) . Thus, while it is possible to explain our results with more complex models that rely on dimer formation, our data were insufficient to define the parameters associated with these models. We conclude that, while this model provides a somewhat improved description of our data (an F-test comparing the fit variances of the dimer-sequential and sequential-linked models gave P 0.025) (P is the probability that the improvement in fit is random rather than significant (Bevington, 1969) , the simpler sequential-linked-site model catches the essence of factor X a 's structural and functional responses to C6PS titration without the need to introduce an unreasonable number of adjustable parameters. This is expected to be true especially for [X a ] . 50 nM and [Ca 2þ ] . 3 mM, for which most X a will be dimer when site 1 is occupied. 3. Binding of C6PS to the first factor X a lipid binding site (EGF NC or DAG site) triggers conformational changes that lead to factor X a dimerization. Because dimer formation accompanies occupancy of site 1, it is appropriate to comment on the evidence for C6PS-induced structural change. First, the fluorescence decrease of 1 nM DEGR-X a followed the sequential-linked-site model, with decreases in fluorescence accompanying occupancy of both C6PS sites (Table 1 ). In gel experiments (Fig. 7) , we confirmed that 1 nM factor X a at 5 mM Ca 2þ did not form dimers, so that the changes in dansyl fluorescence reflect changes in the active site environment of monomer factor X a . Second, a secondary structure change accompanied C6PS binding to site 1 in the absence of Ca 2þ (Fig. 8 B) , when dimer formation is not observed (Fig. 7) . Third, C6PC also induced changes in CD spectra in the presence and absence of Ca 2þ (Fig.  8 ) even though C6PC does not promote dimer formation, as we showed by native polyacrylamide gel. Finally, while it is clear that some part of the structural response seen to C6PS binding in the presence of Ca 2þ is due to dimerization (Fig. 8 A, upper inset) , linear extrapolation of our data to zero percent dimer yielded a Q 222 /Q 208 equal to that induced by C6PS in the absence of Ca 2þ (see description of Fig. 8 A) . These observations provide broad support for our hypothesis that C6PS induces conformational changes in factor X a monomer that, in the presence of Ca 2þ , lead to dimerization, in itself an indication of a structural change.
Are the effects of soluble C6PS due to micelle formation?
Our conclusions depend on our results reflecting the effects of individual C6PS molecules binding to factor X a . We have previously characterized by both probe fluorescence and QELS the CMCs of C6PS, C6PC, and C6PG as a function of Ca 2þ concentration and in the presence of different concentrations of factor X a and prothrombin with and without Ca 2þ and 0.6 wt% poly(ethylene glycol) (Koppaka et al., 1996) . As documented throughout the Results section, we were careful in this work never to analyze data taken at concentrations above the CMC of the short-chain phospholipid under study. We were able to detect micelle formation both by QELS and by monitoring sudden changes in an observable for each experiment as we went above the CMC in C6PS concentration (see Results). The C6PS CMC obtained in these different ways always agreed. Thus, the results we report here reflect the binding of factor X a to soluble lipids, not to lipid micelles.
Aside from the possibility of micelle formation that our controls rule out, Johnson et al. (1981) suggested that shortchain C6PC may exist in an equilibrium mixture of monomers and dimers below the CMC. Because of the net negative charge on C6PS, this probably does not occur for this short-chain lipid. However, if it did, binding of both monomers and dimers of C6PS to a single site on factor X a might cause the observed sigmoidal binding behavior. This possibility can be precluded for several reasons. First, the binding of C6PC to DEGR-X a showed no such behavior (Fig. 2 A, filled triangles) , although C6PC is the lipid actually suggested to form dimers below its CMC (Johnson et al., 1981) . Second, the responses of amidolytic (Fig. 3) and proteolytic activities of factor X a (Koppaka et al., 1996) to soluble lipids showed simple hyperbolic, not sigmoidal, responses to C6PS. This can be explained easily in terms of single C6PS molecules binding to and eliciting different responses from two different sites, but is hard to explain in terms of C6PS binding as a monomer or dimer to a single site. Finally, direct equilibrium dialysis measurements show that, while two soluble C6PS molecules bind to factor X a (Banerjee et al., 2002a) , they bind to different regions of the factor X a molecule . These measurements are unequivocal and are inconsistent with our results being due to binding of C6PS dimers to factor X a .
Relationship of C6PS binding sites to membrane binding
Binding of prothrombin and factor X a to membranes has been well studied. The Gla domain is required for the Ca 2þ -dependent interaction with phospholipid membranes (Henriksen and Jackson, 1975) , and a comparison of binding affinity does show that the Gla domain plus first Kringle domain (termed fragment 1) of prothrombin account for most, but not all, of the membrane-binding free energy (Pearce et al., 1993) . Several models for the mechanism of membrane binding have been proposed: absorption to clusters or domains of 10 or so acidic lipids in the plane of the membrane (Lim et al., 1977; van Dieijen et al., 1981) ; specific occupancy of a limited number (two-four) of PS binding sites (Cutsforth et al., 1989; Tendian and Lentz, 1990) ; membrane insertion of a hydrophobic loop involving residues 5 and 8 of the Gla domain (Christiansen et al., 1995; Falls et al., 2001) ; or formation of a specific lipid-binding pocket involving residues 11, 33, and 34 (McDonald et al., 1997) . While there remains controversy about the mechanism of binding, the prevailing opinion is that membrane binding involves a limited number of sites on factor X a and that the most significant contribution to the free energy of the process derives from the Gla domain. If so, how can a PS site in the EGF NC domain pair be important to membrane binding? The answer is that this site is likely not a significant contributor to the free energy of membrane binding but rather accounts for the effects of PS-containing membranes on factor X a behavior. This follows from the fact that, for every observable that was altered by C6PS, there was a qualitatively similar (but not identical) change due to PScontaining membranes. There was a 70-fold increase in bovine X a autolysis rate when C6PS was present and only a two-to threefold additional increase in the presence of PSmembranes (Fig. 3) . C6PS decreased factor X a amidolytic activity by 55% (Fig. 2) , while PS-containing membranes decreased this activity by 35% (Koppaka et al., 1996) . Adding soluble C6PS produces a saturable 60-fold increase in the rate of prothrombin activation (Banerjee et al., 2002b; Koppaka et al., 1996) , while the rate of prothrombin proteolysis by human factor X a (in the absence of factor V a ) increased by 475-fold at an optimal membrane concentration of 50 mM (Banerjee et al., 2002b; Wu et al., 2002) . However, a substantial fraction of this increase was due to a membrane-surface effect: channeling of intermediate back to the enzyme for rapid conversion to thrombin (Banerjee et al., 2002b; Wu et al., 2002) . Finally, control experiments showed that DEGR-X a fluorescence decreased by 55% upon addition of PS-containing membranes compared to the 25% decrease seen with C6PS. A decrease in human DEGR-X a fluorescence upon titration with PScontaining membranes has previously been interpreted in terms of a membrane-induced change in factor X a structure (Husten et al., 1987) , although, as we point out here, a change in DEGR-X a fluorescence is insufficient to demonstrate a structural change. However, our results do demonstrate C6PS-induced structural changes in factor X a , and the parallels between our measurements with C6PS and with PSmembranes suggest that the decrease in DEGR-X a fluorescence seen in the presence of PS-membranes reflects either structural changes or dimerization, or both, induced by membrane binding. Factor X a dimerization on a PSmembrane would likely have significant implications for how membranes induce the interaction of factors X a and V a in vivo to form prothrombin-activating complex. This deserves further study.
APPENDIX
Model for equilibrium binding of water-soluble phospholipids to DEGR-X a If two ligand-binding sites are linked, and if their occupancy elicits different structural responses, we can write for the net structural response an expression that involves six unknown parameters. A simplification of this model can be made when one site (second site) is unlikely to be occupied without the other being occupied first. Making this assumption eliminates two parameters. This is termed the sequential-linked-site model, and takes the form:
where u ¼ 1 þ ½Lk 1 þ ½L 2 k 1 k 12 , R is the observed structural response, R 0 is the value of R in the absence of ligand, DR sat,1 is the structural response to occupancy of the first site, and DR sat,12 is the response to occupancy of both sites. We had to consider one more model when we demonstrated that factor X a forms dimers in the presence of C6PS. It is easy to show that for a simple dimerization reaction that produces a change in some observable, R, the fraction of protein in a dimer state, f 2 , is:
where C is the total protein concentration, k is the dimer association constant, whose lipid dependence is given in the legend to Fig. 6 , and R 0 and R sat are the values of the observable at limiting low and high protein concentrations, respectively. If we presume that PS binding to a single site enables dimer formation, then a fraction (f 2 ) of the total concentration of the species PL 1 will be dimer and 1 ÿ f 2 will be monomer. We represent the response of the monomer as DR sat,1 and that of the dimer as DR sat,3 to distinguish it from the response due to occupancy of the second site (DR sat, 12 ). We may then write: 
where we have replaced C in Eq. 2 with the concentration of protein bound to a single PS, k 1 3 [L] 3 P T . This makes f 2 not only a function of P T , the total protein concentration in an experiment, but also of the phospholipid concentration added during a titration experiment. This is termed the dimer/ sequential binding model.
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